- Aucune donnée
Français
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
On October 3rd, the 2023 Nobel Prize in Physics was announced, recognizing scientists who have studied attosecond physics, marking the beginning of the attosecond era for humanity.At present, China's first attosecond laser device, the "Advanced attosecond Laser Facility", is being prepared and built in Dongguan, Guangdong, providing strong impetus for breakthroughs in multiple major basic scientif...
Recently, a research team from the University of Massachusetts Amherst has pioneered a new technology that uses laser irradiation on concentric superlenses on chips to generate holograms, thereby achieving precise alignment of 3D semiconductor chips.This research result, published in the journal Nature Communications, is expected to not only reduce the production cost of 2D semiconductor chips, bu...
Researchers from Sichuan University, the Key Laboratory of Advanced Special Materials and Preparation Processing Technology of the Ministry of Education, and the Nuclear Additive Manufacturing Laboratory of China Nuclear Power Research and Design Institute reported on the study of the ultra capillary performance of laser powder bed melting additive manufacturing composite structure liquid absorbin...
Laser is considered a sharp sword that cuts iron like mud, but even sharper swords can have tricky moments. For example, in certain scenarios, there are materials with higher reflectivity, such as silver, copper, etc., known as "high reflection materials". High reflective materials have a low absorption rate for lasers, making them difficult to process and potentially causing equipment failure or ...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...